Published in Drug Law Weekly, September 4th, 2007
Ballenger, a partner at Latham & Watkins, in Washington, D.C., told attendees at an audio conference sponsored by the Food and Drug Law Institute (FDLI), that, in November, the Abigail Alliance would appeal the ruling by the D.C. Circuit Court of Appeals earlier this month that terminally ill patients did not have a constitutional right to drugs still undergoing review by FDA. "This case is important not just for patients...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.